pico 750 wg vanddispergerbart granulat
basf a/s - picolinafen - vanddispergerbart granulat - 750 g/kg picolinafen
safari (reg.nr. 570-22) minigranulat
3a kemi a/s - triflusulfuron-methyl, triflusulfuron - minigranulat - 500 g/kg triflusulfuron-methyl ; (~ 486 g/kg triflusulfuron
applaud 25 sc suspensionskoncentrat
nichino europe limited - buprofezin - suspensionskoncentrat - 250 g/l buprofezin
plenum 50 wg vanddispergerbart granulat
syngenta nordics a/s - pymetrozin - vanddispergerbart granulat - 500 g/kg pymetrozin
previcur n flydende middel
bayer a/s - propamocarb - flydende middel - 640 g/l propamocarb
propeller vandopløseligt koncentrat
nedab aps - propamocarb-hci, propamocarb - vandopløseligt koncentrat - 722 g/l propamocarb-hcl ; (~ 605 g/l propamocarb
ally 20 sx vandopløseligt granulat
fmc agricultural solutions a/s (tidligere: cheminova a/s) - metsulfuron-methyl, metsulfuron - vandopløseligt granulat - 200 g/kg metsulfuron-methyl ; (~ 193 g/kg metsulfuron)
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler til systemisk brug, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler..
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler til systemisk brug, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
ceftriaxon "navamedic" 2 g pulver til infusionsvæske, opløsning
navamedic asa - ceftriaxonnatriumsesquaterhydrate - pulver til infusionsvæske, opløsning - 2 g